Загрузка...
Impact of COVID-19 on patients with atopic dermatitis
Data on the tolerability and response to biologic therapies for type 2 immune disorders in the context of coronavirus disease 2019 (COVID-19) are currently lacking. Our survey aimed at assessing the adherence of patients to dupilumab therapy and the risk of the severe acute respiratory syndrome coro...
Сохранить в:
| Опубликовано в: : | Clin Dermatol |
|---|---|
| Главные авторы: | , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Elsevier Inc.
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8285243/ https://ncbi.nlm.nih.gov/pubmed/34920828 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clindermatol.2021.07.008 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|